Abstract
Stereotactic body radiation therapy (SBRT) is an effective, non-invasive therapeutic modality for treatment of liver malignancies. We report the clinical outcome in 39 patients with primary hepatocellular carcinoma (HCC) treated with SBRT at the University of Rochester Medical Center. Pathologic correlation of tumor response was available in those patients undergoing liver transplant (LT) or resection after SBRT.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
